REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,075,678 | +7.4% | 10,550 | +5.0% | 0.07% | +169.2% |
| Q1 2021 | $1,002,000 | +34.5% | 10,050 | +31.3% | 0.03% | -27.8% |
| Q3 2020 | $745,000 | +1141.7% | 7,652 | +1887.5% | 0.04% | +1100.0% |
| Q2 2020 | $60,000 | -98.5% | 385 | -98.0% | 0.00% | -98.0% |
| Q4 2019 | $3,971,000 | -8.2% | 19,423 | -63.9% | 0.15% | -22.6% |
| Q3 2019 | $4,326,000 | +7.4% | 53,876 | +26.2% | 0.20% | -1.5% |
| Q2 2019 | $4,028,000 | +1479.6% | 42,694 | +244.0% | 0.20% | +942.1% |
| Q1 2018 | $255,000 | – | 12,412 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |